Intrexon reported $73.84M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agenus AGEN:US $ 15.72M 18.72M
Amgen AMGN:US $ 916M 5784M
Anika Therapeutics ANIK:US $ 285.79M 1.3M
Arrowhead Research ARWR:US $ 452.27M 79.71M
AstraZeneca AZN:LN 36340M 2928M
Bluebird Bio BLUE:US $ 263.26M 111.02M
Bristol Myers Squibb BMY:US $ 31580M 4366M
Chemocentryx CCXI:US $ 258.72M 27.4M
Gilead Sciences GILD:US $ 19927M 1142M
GlaxoSmithKline GSK:LN 16181M 1126M
Heron Therapeutics HRTX:US $ 23.96M 53.61M
Immunogen IMGN:US $ 306.47M 19.12M
Intrexon XON:US $ 73.84M 33.51M
Karyopharm Therapeutics KPTI:US $ -83079000 3.41M
Ligand Pharmaceuticals LGND:US $ 793.19M 27.97M
Macrogenics MGNX:US $ 178.21M 61.4M
Mannkind MNKD:US $ -232.06M 22.72M
Merk MRK:US $ 40883M 2699M
Novartis NOVN:VX SF 61540M 6115M
Peregrine Pharmaceuticals PPHM:US $ 56.58M 5.47M
Rigel Pharmaceuticals RIGL:US $ 6.8M 23.58M
Sangamo Biosciences SGMO:US $ 334.52M 40.82M
Thermo Fisher Scientific TMO:US $ 40956M 163M
Veracyte VCYT:US $ 1085.19M 11.32M
Xencor XNCR:US $ 763.02M 29.52M
YTE INCY:US $ 3863.07M 93.07M
Ziopharm Oncology ZIOP:US $ 49.12M 8.94M